A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of 12-Week Administration Of PF-00734200 To Subjects With Type 2 Diabetes Mellitus And Insufficient Glycemic Control On Metformin Treatment
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of 12-Week Administration Of PF-00734200 To Subjects With Type 2 Diabetes Mellitus And Insufficient Glycemic Control On Metformin Treatment
To determine the effect of PF-00734200 on HbA1c in type 2 diabetic subjects receiving metformin
Inclusion Criteria:
Men or women between 18-80 years of age with poorly controlled Type 2 diabetes
Exclusion Criteria:
Type 1 or secondary forms of diabetes Currently using insulin
Greenbrea, California 94904, United States